Statin-associated rhabdomyolysis [2]

Pharmacoepidemiology and Drug Safety

Volumn 14, Issue 4, 2005, Pages 287-

  Ardati, Amer ^a   Stolley, Paul ^a   Knapp, Deanne E ^a   Wolfe, Sidney M ^a   Lurie, Peter ^a  

^a Public Citizen Health Research Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERIVASTATIN; CREATINE KINASE; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

DATA BASE; DRUG FATALITY; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; HUMAN; LETTER; PRIORITY JOURNAL; RHABDOMYOLYSIS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; RHABDOMYOLYSIS; TIME FACTORS;

EID: 17244381558     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.1053     Document Type: Letter

References (1)

1. Chang JT, Staffa JA, Parks M, Green L. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy. Pharmacoepidemiol Drug Safe 2004; 13: 417-426.